Skip to main content
. Author manuscript; available in PMC: 2017 Dec 21.
Published in final edited form as: J Viral Hepat. 2016 Dec 1;24(5):380–388. doi: 10.1111/jvh.12656

TABLE 2.

Baseline characteristics of 9117 participants of NHANES III aged 18–59 years, by anti-HCV and HCV RNA status

Characteristica Anti-HCV negative Anti-HCV positive (RNA positive and negative) Anti-HCV positive and HCV RNA positive (chronic HCV)



N=8866 N=251 P-value* N=203 P-value*
Age (y), mean 36.4 (0.2) 36.4 (0.9) .99 36.9 (1.0) .69

Female, % 52.1 (0.6) 31.0 (4.1) <.001 29.0 (5.2) <.001

Race/ethnicity, %

 Non-Hispanic White 76.0 (1.4) 66.8 (4.8) .006 63.9 (5.9) .006

 Non-Hispanic Black 10.6 (0.7) 18.2 (2.4) 20.4 (3.2)

 Mexican American 10.2 (1.0) 11.2 (2.6) 10.6 (2.5)

 Other 3.2 (0.4) 3.9 (2.2) 5.0 (2.8)

Married, % 62.3 (1.1) 40.3 (4.5) <.001 38.1 (4.7) <.001

Non-high school graduate, % 18.4 (1.1) 39.8 (4.3) <.001 37.5 (4.5) <.001

Current smoker, % 30.7 (1.0) 64.2 (5.5) <.001 69.9 (6.2) <.001

Poverty income ratio, mean 3.18 (0.1) 2.0 (0.2) <.001 1.8 (0.2) <.001

Lifetime no. of sex partners, %

 0–1 23.7 (0.8) 5.4 (1.5) <.001 4.0 (1.7) <.001

 2–9 48.0 (0.9) 33.1 (5.2) 37.7 (5.9)

 10–49 23.9 (1.0) 43.5 (5.4) 41.6 (5.9)

 ≥50 4.3 (0.5) 18.0 (3.2) 16.6 (0.3)

Lifetime cocaine use, %

 Never 87.0 (0.8) 40.7 (5.6) <.001 39.1 (6.5) <.001

 1–10 7.9 (0.6) 17.3 (4.8) 14.5 (4.2)

 >10 5.5 (0.5) 42.0 (6.4) 46.4 (7.2)

Lifetime marijuana use, %

 Never 55.2 (1.3) 20.3 (3.8) <.001 18.8 (4.3) <.001

 1–99 times 33.2 (1.0) 27.2 (4.0) 28.0 (4.5)

 ≥100 11.5 (0.6) 52.5 (5.1) 53.2 (6.1)

Alcohol consumption, %

 <1 drinks/day 91.9 (0.5) 77.4 (5.6) .11 72.8 (6.5) .08

 1–2 drinks/day 7.1 (0.4) 15.8 (4.4) 19.2 (5.6)

 >2 drinks/day 1.9 (0.2) 6.8 (4.7) 8.1 (6.0)

ALT (U/L), mean 18.0 (0.4) 38.4 (2.2) <.001 44.2 (3.0) <.001

Body mass index (kg/m2), mean 26.3 (0.1) 25.6 (0.5) .18 25.5 (0.6) .20

Total bilirubin (mg/dL), mean 10.7 (0.1) 10.7 (0.6) .86 11 (0.8) .70
a

Mean (standard error) or % (standard error).

*

Wald χ2 or t test.